Health Economics Research
Well-being, resilience, prosperity: health is an investment, not a cost. Yet all too often discussions on healthcare systems fail to recognize the value of a healthy population – for citizens, societies, and economies. Our health economics research makes the importance of health investments measurable throughout the world.
The United Nations has set 17 Sustainable Development Goals on its 2030 Agenda. From ending poverty to building resilient infrastructures, achieving each of these goals is contingent on the advancement of global health systems. WifOR strives to empower business, politics, and society to make evidence-based decisions on health using empirical and comparable data. Our vision: better health for all.
Health Economics Research: WifOR’s Approach
- Measure the size, impact, and significance of the Health Economy and its subsectors (Industrial Health Economy, Service and Support, and Healthcare Economy)
- Enable comparison between different sectors in the wider economy, health economies between countries, and contribution to political targets – such as the United Nations’ Sustainable Development Goals
- Identify potential for progress in health, make smart health investments leading to positive health interventions, and generate a Return on Investment (ROI)
Hatice Küçük Beton
Executive Director The G20 Health & Development Partnership
The insight provided by WifOR has been hugely helpful for our research and advocacy, informing our advocacy work on health metrics and financing. WifOR has strengthened the tools we can use to shift the paradigm of viewing health as a cost, to seeing it as an investment.
Executive Director AMIIF
I have learned a lot from the WifOR Institute over the years, especially in how to look at health investments in a holistic way.
Director General EuropaBio
EuropaBio worked with WifOR to establish economic indicators for biotechnology and it was an excellent process of research and industry-oriented outcomes. It is a valuable part of our work to represent biotechnology in Europe.
Latest articles from WifOR’s Health Economics Research
BDI study: Interview with Rabea Knorr
Measuring Return on Investment